{"transactions":[{"id":676016,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-08-25T21:24:22.000Z","date":"2026-08-23","kind":"exercise","planned":false,"acquired":false,"shares":20833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026."}],"balance_after":229167,"derivative":{"underlying":"Common Stock","underlying_shares":20833},"source":{"system":"sec-edgar","filing":"0000950103-26-012870","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010326012870/ownership.xml","form_type":"4"}},{"id":676015,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-25T21:24:22.000Z","date":"2026-08-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":10184,"price":7.2,"value":73324.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs."}],"balance_after":3779521,"source":{"system":"sec-edgar","filing":"0000950103-26-012870","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010326012870/ownership.xml","form_type":"4"}},{"id":676014,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-25T21:24:22.000Z","date":"2026-08-23","kind":"exercise","planned":false,"acquired":true,"shares":20833,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":3789705,"source":{"system":"sec-edgar","filing":"0000950103-26-012870","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010326012870/ownership.xml","form_type":"4"}},{"id":720979,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2026-07-01T22:19:25.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":346836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options are fully vested."}],"balance_after":500164,"derivative":{"exercise_price":2.33,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":346836},"source":{"system":"sec-edgar","filing":"0000950103-26-009978","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010326009978/ownership.xml","form_type":"4"}},{"id":720978,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-01T22:19:25.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":346836,"price":5.89,"value":2042864.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.75 to $6.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":3768872,"source":{"system":"sec-edgar","filing":"0000950103-26-009978","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010326009978/ownership.xml","form_type":"4"}},{"id":720977,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-01T22:19:25.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":346836,"price":2.33,"value":808127.88,"ownership":{"direct":true},"balance_after":4115708,"source":{"system":"sec-edgar","filing":"0000950103-26-009978","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010326009978/ownership.xml","form_type":"4"}},{"id":756900,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-06-01T20:25:49.000Z","date":"2026-05-28","kind":"sale","planned":false,"acquired":false,"shares":119250,"price":4.36,"value":519930.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Precigen common stock sold pursuant to a sell-to-cover transaction to satisfy tax withholding obligations upon the vesting of restricted stock units on May 23, 2026."}],"balance_after":3768872,"source":{"system":"sec-edgar","filing":"0000950103-26-008168","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010326008168/ownership.xml","form_type":"4"}},{"id":761579,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-05-28T00:18:08.000Z","date":"2026-05-23","kind":"exercise","planned":false,"acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents 50% of the RSUs granted on June 26, 2025 that vested on May 23, 2026. The remaining RSUs will vest in equal quarterly installments for three years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents 50% of the RSUs granted on June 26, 2025 that vested on May 23, 2026. The remaining RSUs will vest in equal quarterly installments for three years thereafter."}],"balance_after":250000,"derivative":{"underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000950103-26-007842","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010326007842/ownership.xml","form_type":"4"}},{"id":761578,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-28T00:18:08.000Z","date":"2026-05-23","kind":"exercise","planned":false,"acquired":true,"shares":250000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":3888122,"source":{"system":"sec-edgar","filing":"0000950103-26-007842","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010326007842/ownership.xml","form_type":"4"}},{"id":802647,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-04-22T20:22:42.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":410000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest 25% on May 23, 2027 and in equal six-month installments for three years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest 25% on May 23, 2027 and in equal six-month installments for three years thereafter."}],"balance_after":410000,"derivative":{"underlying":"Common Stock","underlying_shares":410000},"source":{"system":"sec-edgar","filing":"0000950103-26-006044","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010326006044/ownership.xml","form_type":"4"}},{"id":802646,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2026-04-22T20:22:42.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":1366000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on May 23, 2027 and in equal monthly installments for three years thereafter."}],"balance_after":1366000,"derivative":{"exercise_price":4.11,"expiration_date":"2036-04-20","underlying":"Common Stock","underlying_shares":1366000},"source":{"system":"sec-edgar","filing":"0000950103-26-006044","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010326006044/ownership.xml","form_type":"4"}},{"id":832270,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-20T23:27:41.000Z","date":"2026-03-18","kind":"exercise","planned":false,"acquired":false,"shares":321100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested immediately upon the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested immediately upon the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":321100},"source":{"system":"sec-edgar","filing":"0000950103-26-004489","document":"dp243985_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010326004489/dp243985_4-sabzevari.xml","form_type":"4"}},{"id":832269,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-20T23:27:41.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":321100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested immediately upon the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested immediately upon the grant date."}],"balance_after":321100,"derivative":{"underlying":"Common Stock","underlying_shares":321100},"source":{"system":"sec-edgar","filing":"0000950103-26-004489","document":"dp243985_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010326004489/dp243985_4-sabzevari.xml","form_type":"4"}},{"id":832268,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-20T23:27:41.000Z","date":"2026-03-18","kind":"exercise","planned":false,"acquired":true,"shares":321100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":3638122,"source":{"system":"sec-edgar","filing":"0000950103-26-004489","document":"dp243985_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010326004489/dp243985_4-sabzevari.xml","form_type":"4"}},{"id":1039232,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Stock Units","published_at":"2025-09-16T23:47:23.000Z","date":"2025-09-12","kind":"grant","planned":false,"acquired":true,"shares":825000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the vesting of the second installment of performance stock units (\"PSUs\") originally granted on August 28, 2024 based on the achievement of the applicable performance condition for such installment."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU is payable in a share of the Issuer's common stock or in a cash amount having an equivalent value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the vesting of the second installment of performance stock units (\"PSUs\") originally granted on August 28, 2024 based on the achievement of the applicable performance condition for such installment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU is payable in a share of the Issuer's common stock or in a cash amount having an equivalent value."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the vesting of the second installment of performance stock units (\"PSUs\") originally granted on August 28, 2024 based on the achievement of the applicable performance condition for such installment."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each PSU is payable in a share of the Issuer's common stock or in a cash amount having an equivalent value."}],"balance_after":825000,"derivative":{"underlying":"Common Stock","underlying_shares":825000},"source":{"system":"sec-edgar","filing":"0000950103-25-011726","document":"dp234441_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010325011726/dp234441_4-sabzevari.xml","form_type":"4"}},{"id":1100109,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-06-27T20:08:15.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest 50% on May 23, 2026 and in equal monthly installments for three years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest 50% on May 23, 2026 and in equal monthly installments for three years thereafter."}],"balance_after":500000,"derivative":{"underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000950103-25-007990","document":"dp230754_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010325007990/dp230754_4-sabzevari.xml","form_type":"4"}},{"id":1133261,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2025-05-27T23:21:56.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 50% on May 23, 2026 and in equal monthly installments for three years thereafter."}],"balance_after":1000000,"derivative":{"exercise_price":1.37,"expiration_date":"2035-05-23","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000950103-25-006450","document":"dp229264_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010325006450/dp229264_4-sabzevari.xml","form_type":"4"}},{"id":1145158,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-05-16T23:52:21.000Z","date":"2025-05-16","kind":"exercise","planned":false,"acquired":false,"shares":1079137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested in full on May 16, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested in full on May 16, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1079137},"source":{"system":"sec-edgar","filing":"0000950103-25-006143","document":"dp228971_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010325006143/dp228971_4-sabzevari.xml","form_type":"4"}},{"id":1145157,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-05-16T23:52:21.000Z","date":"2025-05-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":521224,"price":1.45,"value":755774.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs."}],"balance_after":3317022,"source":{"system":"sec-edgar","filing":"0000950103-25-006143","document":"dp228971_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010325006143/dp228971_4-sabzevari.xml","form_type":"4"}},{"id":1145156,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-05-16T23:52:21.000Z","date":"2025-05-16","kind":"exercise","planned":false,"acquired":true,"shares":1079137,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":3838246,"source":{"system":"sec-edgar","filing":"0000950103-25-006143","document":"dp228971_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010325006143/dp228971_4-sabzevari.xml","form_type":"4"}},{"id":1169058,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-04-18T20:58:40.000Z","date":"2025-04-17","kind":"grant","planned":false,"acquired":true,"shares":1079137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest in full on May 16, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest in full on May 16, 2025."}],"balance_after":1079137,"derivative":{"underlying":"Common Stock","underlying_shares":1079137},"source":{"system":"sec-edgar","filing":"0000950103-25-005063","document":"dp227908_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010325005063/dp227908_4-sabzevari.xml","form_type":"4"}},{"id":1287228,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-04T01:07:54.000Z","date":"2025-01-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":286967,"price":1.3,"value":373057.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of Common Stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the PSUs."}],"balance_after":2759109,"source":{"system":"sec-edgar","filing":"0000950103-25-001481","document":"dp224422_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010325001481/dp224422_4-sabzevari.xml","form_type":"4"}},{"id":1287227,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-04T01:07:54.000Z","date":"2025-01-29","kind":"grant","planned":false,"acquired":true,"shares":825000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represent shares of Precigen common stock (\"Common Stock\") issued on settlement of the first installment of performance stock units (\"PSUs\") originally granted on August 28, 2024 that vested based on the achievement of the applicable performance condition for such installment."}],"balance_after":3046076,"source":{"system":"sec-edgar","filing":"0000950103-25-001481","document":"dp224422_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010325001481/dp224422_4-sabzevari.xml","form_type":"4"}},{"id":1496535,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2024-05-31T23:03:41.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":1803000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on May 31, 2025 and in equal monthly installments for three years thereafter."}],"balance_after":1803000,"derivative":{"exercise_price":1.4,"expiration_date":"2034-05-31","underlying":"Common Stock","underlying_shares":1803000},"source":{"system":"sec-edgar","filing":"0000950103-24-007574","document":"dp212126_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010324007574/dp212126_4-sabzevari.xml","form_type":"4"}},{"id":1544447,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-04-10T00:59:37.000Z","date":"2024-04-05","kind":"exercise","planned":false,"acquired":false,"shares":1071429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested immediately upon the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested immediately upon the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1071429},"source":{"system":"sec-edgar","filing":"0000950103-24-005095","document":"dp209631_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010324005095/dp209631_4-sabzevari.xml","form_type":"4"}},{"id":1544446,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-04-10T00:59:37.000Z","date":"2024-04-05","kind":"grant","planned":false,"acquired":true,"shares":1071429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested immediately upon the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested immediately upon the grant date."}],"balance_after":1071429,"derivative":{"underlying":"Common Stock","underlying_shares":1071429},"source":{"system":"sec-edgar","filing":"0000950103-24-005095","document":"dp209631_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010324005095/dp209631_4-sabzevari.xml","form_type":"4"}},{"id":1544445,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-04-10T00:59:37.000Z","date":"2024-04-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":410357,"price":1.4,"value":574499.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs."}],"balance_after":2221076,"source":{"system":"sec-edgar","filing":"0000950103-24-005095","document":"dp209631_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010324005095/dp209631_4-sabzevari.xml","form_type":"4"}},{"id":1544444,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-04-10T00:59:37.000Z","date":"2024-04-05","kind":"exercise","planned":false,"acquired":true,"shares":1071429,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":2631433,"source":{"system":"sec-edgar","filing":"0000950103-24-005095","document":"dp209631_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010324005095/dp209631_4-sabzevari.xml","form_type":"4"}},{"id":1546796,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-05T16:55:16.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option was cancelled  pursuant to that certain Agreement and Plan of Merger, dated February 16, 2024, by and between the Issuer, XOMA Corporation and XRA 1 Corp. (the \"Merger Agreement\") in exchange for one non-transferable contingent value right (\"CVR\") for each share underlying such out-of-the-money option. However, please note that such CVRs will provide payment only after the amounts payable under such CVRs exceed a threshold equal to the excess of the per share exercise price of such out-of-the-money option over the Cash Amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was cancelled  pursuant to that certain Agreement and Plan of Merger, dated February 16, 2024, by and between the Issuer, XOMA Corporation and XRA 1 Corp. (the \"Merger Agreement\") in exchange for one non-transferable contingent value right (\"CVR\") for each share underlying such out-of-the-money option. However, please note that such CVRs will provide payment only after the amounts payable under such CVRs exceed a threshold equal to the excess of the per share exercise price of such out-of-the-money option over the Cash Amount."}],"balance_after":0,"derivative":{"exercise_price":8.38,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":20250},"source":{"system":"sec-edgar","filing":"0001415889-24-010426","document":"form4-04052024_040406.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000141588924010426/form4-04052024_040406.xml","form_type":"4"}},{"id":1546795,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-05T16:55:16.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option was cancelled  pursuant to that certain Agreement and Plan of Merger, dated February 16, 2024, by and between the Issuer, XOMA Corporation and XRA 1 Corp. (the \"Merger Agreement\") in exchange for one non-transferable contingent value right (\"CVR\") for each share underlying such out-of-the-money option. However, please note that such CVRs will provide payment only after the amounts payable under such CVRs exceed a threshold equal to the excess of the per share exercise price of such out-of-the-money option over the Cash Amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was cancelled  pursuant to that certain Agreement and Plan of Merger, dated February 16, 2024, by and between the Issuer, XOMA Corporation and XRA 1 Corp. (the \"Merger Agreement\") in exchange for one non-transferable contingent value right (\"CVR\") for each share underlying such out-of-the-money option. However, please note that such CVRs will provide payment only after the amounts payable under such CVRs exceed a threshold equal to the excess of the per share exercise price of such out-of-the-money option over the Cash Amount."}],"balance_after":0,"derivative":{"exercise_price":3.48,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-24-010426","document":"form4-04052024_040406.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000141588924010426/form4-04052024_040406.xml","form_type":"4"}},{"id":1546794,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-05T16:55:16.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40501,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option was cancelled  pursuant to that certain Agreement and Plan of Merger, dated February 16, 2024, by and between the Issuer, XOMA Corporation and XRA 1 Corp. (the \"Merger Agreement\") in exchange for one non-transferable contingent value right (\"CVR\") for each share underlying such out-of-the-money option. However, please note that such CVRs will provide payment only after the amounts payable under such CVRs exceed a threshold equal to the excess of the per share exercise price of such out-of-the-money option over the Cash Amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was cancelled  pursuant to that certain Agreement and Plan of Merger, dated February 16, 2024, by and between the Issuer, XOMA Corporation and XRA 1 Corp. (the \"Merger Agreement\") in exchange for one non-transferable contingent value right (\"CVR\") for each share underlying such out-of-the-money option. However, please note that such CVRs will provide payment only after the amounts payable under such CVRs exceed a threshold equal to the excess of the per share exercise price of such out-of-the-money option over the Cash Amount."}],"balance_after":0,"derivative":{"exercise_price":24.38,"expiration_date":"2031-06-24","underlying":"Common Stock","underlying_shares":40501},"source":{"system":"sec-edgar","filing":"0001415889-24-010426","document":"form4-04052024_040406.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000141588924010426/form4-04052024_040406.xml","form_type":"4"}},{"id":1796244,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-08-25T23:04:24.000Z","date":"2023-08-23","kind":"exercise","planned":true,"acquired":false,"shares":141587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 23, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 23, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":141587},"source":{"system":"sec-edgar","filing":"0000950103-23-012774","document":"dp199184_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323012774/dp199184_4-sabzevari.xml","form_type":"4"}},{"id":1796243,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-25T23:04:24.000Z","date":"2023-08-25","kind":"sale","planned":true,"acquired":false,"shares":76969,"price":1.53,"value":117762.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs pursuant to the terms of a 10b5-1 plan adopted by the reporting person. The sale was effected through an automatic \"sell to cover\" transaction that did not represent a discretionary trade by the reporting person."}],"balance_after":1560004,"source":{"system":"sec-edgar","filing":"0000950103-23-012774","document":"dp199184_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323012774/dp199184_4-sabzevari.xml","form_type":"4"}},{"id":1796242,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-25T23:04:24.000Z","date":"2023-08-23","kind":"exercise","planned":true,"acquired":true,"shares":141587,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":1636973,"source":{"system":"sec-edgar","filing":"0000950103-23-012774","document":"dp199184_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323012774/dp199184_4-sabzevari.xml","form_type":"4"}},{"id":1801773,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-08-19T01:06:39.000Z","date":"2023-08-16","kind":"exercise","planned":true,"acquired":false,"shares":141587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 16, 2023. The remaining RSUs vest on August 23, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 16, 2023. The remaining RSUs vest on August 23, 2023."}],"balance_after":141587,"derivative":{"underlying":"Common Stock","underlying_shares":141587},"source":{"system":"sec-edgar","filing":"0000950103-23-012318","document":"dp198761_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323012318/dp198761_4-sabzevari.xml","form_type":"4"}},{"id":1801772,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-19T01:06:39.000Z","date":"2023-08-18","kind":"sale","planned":true,"acquired":false,"shares":55855,"price":1.66,"value":92719.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs pursuant to the terms of a 10b5-1 plan adopted by the reporting person. The sale was effected through an automatic \"sell to cover\" transaction that did not represent a discretionary trade by the reporting person."}],"balance_after":1495386,"source":{"system":"sec-edgar","filing":"0000950103-23-012318","document":"dp198761_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323012318/dp198761_4-sabzevari.xml","form_type":"4"}},{"id":1801771,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-19T01:06:39.000Z","date":"2023-08-16","kind":"exercise","planned":true,"acquired":true,"shares":141587,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":1551241,"source":{"system":"sec-edgar","filing":"0000950103-23-012318","document":"dp198761_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323012318/dp198761_4-sabzevari.xml","form_type":"4"}},{"id":1809720,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-08-11T23:24:42.000Z","date":"2023-08-09","kind":"exercise","planned":true,"acquired":false,"shares":141587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 9, 2023. The remaining RSUs vest in two equal installments on each of August 16, 2023 and August 23, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 9, 2023. The remaining RSUs vest in two equal installments on each of August 16, 2023 and August 23, 2023."}],"balance_after":283173,"derivative":{"underlying":"Common Stock","underlying_shares":141587},"source":{"system":"sec-edgar","filing":"0000950103-23-011942","document":"dp198385_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323011942/dp198385_4-sabzevari.xml","form_type":"4"}},{"id":1809719,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-11T23:24:42.000Z","date":"2023-08-11","kind":"sale","planned":true,"acquired":false,"shares":41436,"price":1.44,"value":59667.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs pursuant to the terms of a 10b5-1 plan adopted by the reporting person. The sale was effected through an automatic \"sell to cover\" transaction that did not represent a discretionary trade by the reporting person."}],"balance_after":1409654,"source":{"system":"sec-edgar","filing":"0000950103-23-011942","document":"dp198385_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323011942/dp198385_4-sabzevari.xml","form_type":"4"}},{"id":1809718,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-11T23:24:42.000Z","date":"2023-08-09","kind":"exercise","planned":true,"acquired":true,"shares":141587,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":1451090,"source":{"system":"sec-edgar","filing":"0000950103-23-011942","document":"dp198385_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323011942/dp198385_4-sabzevari.xml","form_type":"4"}},{"id":1814805,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-08-04T23:05:44.000Z","date":"2023-08-02","kind":"exercise","planned":true,"acquired":false,"shares":141587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 2, 2023. The remaining RSUs vest in three equal installments on each of August 9, 2023, August 16, 2023 and August 23, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 2, 2023. The remaining RSUs vest in three equal installments on each of August 9, 2023, August 16, 2023 and August 23, 2023."}],"balance_after":424760,"derivative":{"underlying":"Common Stock","underlying_shares":141587},"source":{"system":"sec-edgar","filing":"0000950103-23-011610","document":"dp198085_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323011610/dp198085_4-sabzevari.xml","form_type":"4"}},{"id":1814804,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-04T23:05:44.000Z","date":"2023-08-04","kind":"sale","planned":true,"acquired":false,"shares":52870,"price":1.1,"value":58157.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs pursuant to the terms of a 10b5-1 plan adopted by the Reporting Person. The sale was effected through an automatic \"sell to cover\" transaction that did not represent a discretionary trade by the reporting person."}],"balance_after":1309503,"source":{"system":"sec-edgar","filing":"0000950103-23-011610","document":"dp198085_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323011610/dp198085_4-sabzevari.xml","form_type":"4"}},{"id":1814803,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-04T23:05:44.000Z","date":"2023-08-02","kind":"exercise","planned":true,"acquired":true,"shares":141587,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":1362373,"source":{"system":"sec-edgar","filing":"0000950103-23-011610","document":"dp198085_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323011610/dp198085_4-sabzevari.xml","form_type":"4"}},{"id":1857314,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-13T18:32:45.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares underlying the Option vest and become exercisable on a monthly basis starting July 12, 2023 (the Vest Base Date) and thereafter on the same day of the month as the Vest Base Date or if earlier, the day immediately before the date of the next Annual Meeting of Stockholders that occurs after the Vest Base Date."}],"balance_after":25000,"derivative":{"exercise_price":3.48,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-036867","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919123036867/doc4.xml","form_type":"4"}},{"id":1908117,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2023-05-02T21:53:43.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":1732300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on April 28, 2024 and in equal monthly installments for three years thereafter."}],"balance_after":1732300,"derivative":{"exercise_price":1.21,"expiration_date":"2033-04-28","underlying":"Common Stock","underlying_shares":1732300},"source":{"system":"sec-edgar","filing":"0000950103-23-006763","document":"dp193270_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323006763/dp193270_4-sabzevari.xml","form_type":"4"}},{"id":1936736,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2023-03-29T01:08:19.000Z","date":"2023-03-24","kind":"grant","planned":false,"acquired":true,"shares":369596,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":369596,"derivative":{"exercise_price":0.96,"exercise_date":"2024-03-24","expiration_date":"2033-03-24","underlying":"Common Stock","underlying_shares":369596},"source":{"system":"sec-edgar","filing":"0000950103-23-004824","document":"dp191370_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323004824/dp191370_4-sabzevari.xml","form_type":"4"}},{"id":1936735,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-03-29T01:08:19.000Z","date":"2023-03-24","kind":"exercise","planned":false,"acquired":false,"shares":283173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately."}],"balance_after":566347,"derivative":{"underlying":"Common Stock","underlying_shares":283173},"source":{"system":"sec-edgar","filing":"0000950103-23-004824","document":"dp191370_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323004824/dp191370_4-sabzevari.xml","form_type":"4"}},{"id":1936734,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-03-29T01:08:19.000Z","date":"2023-03-24","kind":"grant","planned":false,"acquired":true,"shares":849520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023."}],"balance_after":849520,"derivative":{"underlying":"Common Stock","underlying_shares":849520},"source":{"system":"sec-edgar","filing":"0000950103-23-004824","document":"dp191370_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323004824/dp191370_4-sabzevari.xml","form_type":"4"}},{"id":1936733,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-29T01:08:19.000Z","date":"2023-03-24","kind":"exercise","planned":false,"acquired":true,"shares":283173,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":1220786,"source":{"system":"sec-edgar","filing":"0000950103-23-004824","document":"dp191370_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323004824/dp191370_4-sabzevari.xml","form_type":"4"}},{"id":2042049,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-31T00:23:01.000Z","date":"2023-01-27","kind":"purchase","acquired":true,"shares":22857,"price":1.75,"value":39999.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person purchased shares of Precigen common stock (\"Common Stock\") in connection with the issuer's follow-on offering, which closed on January 27, 2023. The purchase price is the offering price."}],"balance_after":937613,"source":{"system":"sec-edgar","filing":"0000950103-23-001415","document":"dp187977_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323001415/dp187977_4-sabzevari.xml","form_type":"4"}},{"id":2060266,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-01-06T21:05:43.000Z","date":"2023-01-04","kind":"exercise","acquired":false,"shares":17665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were granted on January 4, 2019 and January 25, 2019 and have vested in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were granted on January 4, 2019 and January 25, 2019 and have vested in full."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17665},"source":{"system":"sec-edgar","filing":"0000950103-23-000200","document":"dp186714_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323000200/dp186714_4-sabzevari.xml","form_type":"4"}},{"id":2060265,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-06T21:05:43.000Z","date":"2023-01-04","kind":"exercise","acquired":true,"shares":17665,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":914756,"source":{"system":"sec-edgar","filing":"0000950103-23-000200","document":"dp186714_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323000200/dp186714_4-sabzevari.xml","form_type":"4"}},{"id":2231543,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-15T17:01:14.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":20250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares underlying the Option vest and become exercisable on a monthly basis starting July 13, 2022 (the Vest Base Date) and thereafter on the same day of the month as the Vest Base Date or if earlier, the day immediately before the date of the next Annual Meeting of Stockholders that occurs after the Vest Base Date."}],"balance_after":20250,"derivative":{"exercise_price":8.38,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":20250},"source":{"system":"sec-edgar","filing":"0001209191-22-037029","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919122037029/doc4.xml","form_type":"4"}},{"id":2270120,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-05-16T22:57:35.000Z","date":"2022-05-12","kind":"exercise","acquired":false,"shares":340909,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on March 18, 2022 and have vested in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on March 18, 2022 and have vested in full."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":340909},"source":{"system":"sec-edgar","filing":"0000950103-22-008541","document":"dp173213_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010322008541/dp173213_4-sabzevari.xml","form_type":"4"}},{"id":2270119,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-05-16T22:57:35.000Z","date":"2022-05-13","kind":"sale","acquired":false,"shares":177968,"price":1.1852,"value":210927.6736,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs."}],"balance_after":897091,"source":{"system":"sec-edgar","filing":"0000950103-22-008541","document":"dp173213_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010322008541/dp173213_4-sabzevari.xml","form_type":"4"}},{"id":2270118,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-05-16T22:57:35.000Z","date":"2022-05-12","kind":"exercise","acquired":true,"shares":340909,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":1075059,"source":{"system":"sec-edgar","filing":"0000950103-22-008541","document":"dp173213_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010322008541/dp173213_4-sabzevari.xml","form_type":"4"}},{"id":2321155,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-03-22T21:03:20.000Z","date":"2022-03-18","kind":"grant","acquired":true,"shares":340909,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on May 12, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on May 12, 2022."}],"balance_after":340909,"derivative":{"underlying":"Common Stock","underlying_shares":340909},"source":{"system":"sec-edgar","filing":"0000950103-22-005051","document":"dp169631_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010322005051/dp169631_4-sabzevari.xml","form_type":"4"}},{"id":2411555,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2022-02-04T22:06:58.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":847000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal installments on each of February 2, 2023, February 2, 2024, February 2, 2025 and February 2, 2026."}],"balance_after":847000,"derivative":{"exercise_price":2.33,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":847000},"source":{"system":"sec-edgar","filing":"0000950103-22-002079","document":"dp166687_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010322002079/dp166687_4-sabzevari.xml","form_type":"4"}},{"id":2441269,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-01-06T22:08:59.000Z","date":"2022-01-04","kind":"exercise","acquired":false,"shares":17667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on January 4, 2019 and January 25, 2019 and the remaining RSUs vest on January 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on January 4, 2019 and January 25, 2019 and the remaining RSUs vest on January 4, 2023."}],"balance_after":17665,"derivative":{"underlying":"Common Stock","underlying_shares":17667},"source":{"system":"sec-edgar","filing":"0000950103-22-000271","document":"dp164823_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010322000271/dp164823_4-sabzevari.xml","form_type":"4"}},{"id":2441268,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-06T22:08:59.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":5603,"price":3.5901,"value":20115.3303,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs."}],"balance_after":734150,"source":{"system":"sec-edgar","filing":"0000950103-22-000271","document":"dp164823_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010322000271/dp164823_4-sabzevari.xml","form_type":"4"}},{"id":2441267,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-06T22:08:59.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":1357,"price":3.59,"value":4871.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs."}],"balance_after":739753,"source":{"system":"sec-edgar","filing":"0000950103-22-000271","document":"dp164823_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010322000271/dp164823_4-sabzevari.xml","form_type":"4"}},{"id":2441266,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-06T22:08:59.000Z","date":"2022-01-04","kind":"exercise","acquired":true,"shares":17667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":741110,"source":{"system":"sec-edgar","filing":"0000950103-22-000271","document":"dp164823_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010322000271/dp164823_4-sabzevari.xml","form_type":"4"}},{"id":2448486,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-01-04T22:07:28.000Z","date":"2022-01-02","kind":"exercise","acquired":false,"shares":9765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on January 2, 2018 and have vested in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on January 2, 2018 and have vested in full."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9765},"source":{"system":"sec-edgar","filing":"0000950103-22-000138","document":"dp164713_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010322000138/dp164713_4-sabzevari.xml","form_type":"4"}},{"id":2448485,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-04T22:07:28.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":3848,"price":3.6701,"value":14122.5448,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs."}],"balance_after":723443,"source":{"system":"sec-edgar","filing":"0000950103-22-000138","document":"dp164713_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010322000138/dp164713_4-sabzevari.xml","form_type":"4"}},{"id":2448484,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-04T22:07:28.000Z","date":"2022-01-02","kind":"exercise","acquired":true,"shares":9765,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":727291,"source":{"system":"sec-edgar","filing":"0000950103-22-000138","document":"dp164713_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010322000138/dp164713_4-sabzevari.xml","form_type":"4"}},{"id":2629176,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-07-20T22:11:00.000Z","date":"2021-07-17","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit ('RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on March 28, 2018 and have vested in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on March 28, 2018 and have vested in full."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950103-21-010821","document":"dp154661_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010321010821/dp154661_4-sabzevari.xml","form_type":"4"}},{"id":2629175,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-20T22:11:00.000Z","date":"2021-07-19","kind":"sale","acquired":false,"shares":12531,"price":5.4303,"value":68047.0893,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs."}],"balance_after":717526,"source":{"system":"sec-edgar","filing":"0000950103-21-010821","document":"dp154661_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010321010821/dp154661_4-sabzevari.xml","form_type":"4"}},{"id":2629174,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-20T22:11:00.000Z","date":"2021-07-17","kind":"exercise","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit ('RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":730057,"source":{"system":"sec-edgar","filing":"0000950103-21-010821","document":"dp154661_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010321010821/dp154661_4-sabzevari.xml","form_type":"4"}},{"id":2653700,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-28T13:04:09.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":40501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares underlying the Option vest and become exercisable on each monthly anniversary of the Date of Grant."}],"balance_after":40501,"derivative":{"exercise_price":24.38,"expiration_date":"2031-06-24","underlying":"Common Stock","underlying_shares":40501},"source":{"system":"sec-edgar","filing":"0001209191-21-043448","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919121043448/doc4.xml","form_type":"4"}},{"id":2712167,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-05-14T22:43:52.000Z","date":"2021-05-12","kind":"exercise","acquired":false,"shares":97276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit ('RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on March 25, 2021 and have vested in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on March 25, 2021 and have vested in full."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":97276},"source":{"system":"sec-edgar","filing":"0000950103-21-007276","document":"dp151110_4-sabzevari.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010321007276/dp151110_4-sabzevari.xml","form_type":"4"}},{"id":2712166,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-14T22:43:52.000Z","date":"2021-05-13","kind":"sale","acquired":false,"shares":47433,"price":6.4,"value":303571.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs."}],"balance_after":705057,"source":{"system":"sec-edgar","filing":"0000950103-21-007276","document":"dp151110_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010321007276/dp151110_4-sabzevari.xml","form_type":"4"}},{"id":2712165,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-14T22:43:52.000Z","date":"2021-05-12","kind":"exercise","acquired":true,"shares":97276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit ('RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":752490,"source":{"system":"sec-edgar","filing":"0000950103-21-007276","document":"dp151110_4-sabzevari.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000095010321007276/dp151110_4-sabzevari.xml","form_type":"4"}},{"id":2769206,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-03-29T23:53:15.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":97276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit ('RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on May 12, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on May 12, 2021."}],"balance_after":97276,"derivative":{"underlying":"Common Stock","underlying_shares":97276},"source":{"system":"sec-edgar","filing":"0001123292-21-000571","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329221000571/edgar.xml","form_type":"4"}},{"id":2913551,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-01-07T21:26:16.000Z","date":"2021-01-05","kind":"exercise","acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit ('RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on January 5, 2020 and have vested in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on January 5, 2020 and have vested in full."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001123292-21-000061","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329221000061/edgar.xml","form_type":"4"}},{"id":2913550,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-07T21:26:16.000Z","date":"2021-01-06","kind":"sale","acquired":false,"shares":260045,"price":8.9159,"value":2318535.2155,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs."}],"balance_after":655214,"source":{"system":"sec-edgar","filing":"0001123292-21-000061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329221000061/edgar.xml","form_type":"4"}},{"id":2913549,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-07T21:26:16.000Z","date":"2021-01-05","kind":"exercise","acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit ('RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":915259,"source":{"system":"sec-edgar","filing":"0001123292-21-000061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329221000061/edgar.xml","form_type":"4"}},{"id":2915213,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-01-06T21:37:53.000Z","date":"2021-01-04","kind":"exercise","acquired":false,"shares":17667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit ('RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on January 4, 2019 and January 25, 2019, and the remaining RSUs vest in two equal annual installments on each of January 4, 2022 and 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on January 4, 2019 and January 25, 2019, and the remaining RSUs vest in two equal annual installments on each of January 4, 2022 and 2023."}],"balance_after":35332,"derivative":{"underlying":"Common Stock","underlying_shares":17667},"source":{"system":"sec-edgar","filing":"0001123292-21-000057","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329221000057/edgar.xml","form_type":"4"}},{"id":2915212,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-06T21:37:53.000Z","date":"2021-01-05","kind":"sale","acquired":false,"shares":9040,"price":10.5649,"value":95506.696,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs."}],"balance_after":415259,"source":{"system":"sec-edgar","filing":"0001123292-21-000057","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329221000057/edgar.xml","form_type":"4"}},{"id":2915211,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-06T21:37:53.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":17667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit ('RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":424299,"source":{"system":"sec-edgar","filing":"0001123292-21-000057","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329221000057/edgar.xml","form_type":"4"}},{"id":4612810,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-01-05T22:33:58.000Z","date":"2021-01-02","kind":"exercise","acquired":false,"shares":9766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on January 2, 2018, and the remaining RSUs vest on January 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on January 2, 2018, and the remaining RSUs vest on January 2, 2022."}],"balance_after":9765,"derivative":{"underlying":"Common Stock","underlying_shares":9766},"source":{"system":"sec-edgar","filing":"0001123292-21-000034","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329221000034/edgar.xml","form_type":"4"}},{"id":4612809,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-05T22:33:58.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":5279,"price":10.16,"value":53634.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs."}],"balance_after":406632,"source":{"system":"sec-edgar","filing":"0001123292-21-000034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329221000034/edgar.xml","form_type":"4"}},{"id":4612808,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-05T22:33:58.000Z","date":"2021-01-02","kind":"exercise","acquired":true,"shares":9766,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":411911,"source":{"system":"sec-edgar","filing":"0001123292-21-000034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329221000034/edgar.xml","form_type":"4"}},{"id":3078677,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2020-07-21T22:40:37.000Z","date":"2020-07-17","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on March 28, 2018 and the remaining restricted stock units vest on July 17, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on March 28, 2018 and the remaining restricted stock units vest on July 17, 2021."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001123292-20-000987","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329220000987/edgar.xml","form_type":"4"}},{"id":3078676,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-07-21T22:40:37.000Z","date":"2020-07-20","kind":"sale","acquired":false,"shares":12220,"price":4.58,"value":55967.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units."}],"balance_after":402145,"source":{"system":"sec-edgar","filing":"0001123292-20-000987","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329220000987/edgar.xml","form_type":"4"}},{"id":3078675,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-07-21T22:40:37.000Z","date":"2020-07-17","kind":"exercise","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Precigen common stock."}],"balance_after":414365,"source":{"system":"sec-edgar","filing":"0001123292-20-000987","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329220000987/edgar.xml","form_type":"4"}},{"id":3145249,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2020-05-18T20:04:23.000Z","date":"2020-05-14","kind":"exercise","acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on March 23, 2020 and have vested in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on March 23, 2020 and have vested in full."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001123292-20-000724","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329220000724/edgar.xml","form_type":"4"}},{"id":3145248,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-18T20:04:23.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":217527,"price":2.3712,"value":515800.0224,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units."}],"balance_after":389365,"source":{"system":"sec-edgar","filing":"0001123292-20-000724","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329220000724/edgar.xml","form_type":"4"}},{"id":3145247,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-18T20:04:23.000Z","date":"2020-05-14","kind":"exercise","acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Precigen common stock."}],"balance_after":606892,"source":{"system":"sec-edgar","filing":"0001123292-20-000724","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329220000724/edgar.xml","form_type":"4"}},{"id":3186230,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2020-04-02T20:37:45.000Z","date":"2020-03-31","kind":"exercise","acquired":false,"shares":14340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on April 9, 2019 and have vested in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on April 9, 2019 and have vested in full."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14340},"source":{"system":"sec-edgar","filing":"0001123292-20-000640","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329220000640/edgar.xml","form_type":"4"}},{"id":3186229,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-04-02T20:37:45.000Z","date":"2020-04-01","kind":"sale","acquired":false,"shares":5450,"price":3.0119,"value":16414.855,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units."}],"balance_after":106892,"source":{"system":"sec-edgar","filing":"0001123292-20-000640","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329220000640/edgar.xml","form_type":"4"}},{"id":3186228,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-04-02T20:37:45.000Z","date":"2020-03-31","kind":"exercise","acquired":true,"shares":14340,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Precigen common stock."}],"balance_after":112342,"source":{"system":"sec-edgar","filing":"0001123292-20-000640","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329220000640/edgar.xml","form_type":"4"}},{"id":3197814,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2020-03-23T20:39:17.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on May 14, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on May 14, 2020."}],"balance_after":500000,"derivative":{"underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001123292-20-000608","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329220000608/edgar.xml","form_type":"4"}},{"id":3316181,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2020-01-07T22:13:27.000Z","date":"2020-01-05","kind":"grant","acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in four equal annual installments beginning on January 5, 2021."}],"balance_after":1500000,"derivative":{"exercise_price":17.85,"expiration_date":"2030-01-05","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001123292-20-000110","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329220000110/edgar.xml","form_type":"4"}},{"id":3316180,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2020-01-07T22:13:27.000Z","date":"2020-01-05","kind":"grant","acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in four equal annual installments beginning on January 5, 2021."}],"balance_after":1500000,"derivative":{"exercise_price":11.9,"expiration_date":"2030-01-05","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001123292-20-000110","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329220000110/edgar.xml","form_type":"4"}},{"id":3316179,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2020-01-07T22:13:27.000Z","date":"2020-01-05","kind":"grant","acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests in four installments as follows: 50% on January 5, 2021, and the remaining 50% in three equal annual installments on each of January 5, 2022, 2023, and 2024."}],"balance_after":1500000,"derivative":{"exercise_price":5.95,"expiration_date":"2030-01-05","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001123292-20-000110","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329220000110/edgar.xml","form_type":"4"}},{"id":3316178,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2020-01-07T22:13:27.000Z","date":"2020-01-05","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in full on January 5, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in full on January 5, 2021."}],"balance_after":500000,"derivative":{"underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001123292-20-000110","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329220000110/edgar.xml","form_type":"4"}},{"id":3316177,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2020-01-07T22:13:27.000Z","date":"2020-01-04","kind":"exercise","acquired":false,"shares":17667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on January 4, 2019 and January 25, 2019, and the remaining restricted stock units vest in three equal annual installments on each of January 4, 2021, 2022, and 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on January 4, 2019 and January 25, 2019, and the remaining restricted stock units vest in three equal annual installments on each of January 4, 2021, 2022, and 2023."}],"balance_after":52999,"derivative":{"underlying":"Common Stock","underlying_shares":17667},"source":{"system":"sec-edgar","filing":"0001123292-20-000110","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329220000110/edgar.xml","form_type":"4"}},{"id":3316176,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-01-07T22:13:27.000Z","date":"2020-01-06","kind":"sale","acquired":false,"shares":6732,"price":5.8293,"value":39242.8476,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units."}],"balance_after":98002,"source":{"system":"sec-edgar","filing":"0001123292-20-000110","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329220000110/edgar.xml","form_type":"4"}},{"id":3316175,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-01-07T22:13:27.000Z","date":"2020-01-04","kind":"exercise","acquired":true,"shares":17667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."}],"balance_after":104734,"source":{"system":"sec-edgar","filing":"0001123292-20-000110","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329220000110/edgar.xml","form_type":"4"}},{"id":3318083,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":19860,"kind":"person","name":"Sabzevari Helen","position":1,"cik":"0001724195","reported_name":"Sabzevari Helen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2020-01-06T21:16:08.000Z","date":"2020-01-02","kind":"exercise","acquired":true,"shares":9766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on January 2, 2018, and the remaining restricted stock units vest in two equal annual installments on each of January 2, 2021 and 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on January 2, 2018, and the remaining restricted stock units vest in two equal annual installments on each of January 2, 2021 and 2022."}],"balance_after":19531,"derivative":{"underlying":"Common Stock","underlying_shares":9766},"source":{"system":"sec-edgar","filing":"0001123292-20-000069","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329220000069/edgar.xml","form_type":"4"}}],"next_cursor":"2020-01-06T21:16:08.000000Z,3318083"}